Scarica l'app Stockscreener
21.09
4.09%
-0.90
Dopo l'orario di chiusura:
21.00
-0.09
-0.43%
Precedente Chiudi:
$21.99
Aprire:
$21.69
Volume 24 ore:
5.27M
Relative Volume:
0.75
Capitalizzazione di mercato:
$10.48B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
52.72
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
-1.86%
1M Prestazione:
+4.30%
6M Prestazione:
+63.74%
1 anno Prestazione:
+50.21%
Intervallo 1D:
$21.07
$21.89
Intervallo di 1 settimana:
$21.07
$23.09
Portata 52W:
$8.02
$23.09
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
450 ELANCO CIRCLE, INDIANAPOLIS
Confronta ELAN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
21.09 | 10.93B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
120.82 | 53.39B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.29 | 44.99B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.59 | 44.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
25.41 | 29.30B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
466.40 | 19.91B | 3.08B | 1.24B | 1.07B | 25.61 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Can Elanco Animal Health Incorporated (5EA) stock double in coming yearsPortfolio Risk Report & Intraday High Probability Alerts - newser.com
Will Elanco Animal Health Incorporated (5EA) stock benefit from mergersQuarterly Portfolio Review & Verified Momentum Watchlists - newser.com
Will Elanco Animal Health Incorporated stock beat international competitionJuly 2025 Summary & Free Safe Entry Trade Signal Reports - newser.com
Will Elanco Animal Health Incorporated stock deliver shareholder valueJuly 2025 Momentum & Low Drawdown Momentum Trade Ideas - newser.com
Will Elanco Animal Health Incorporated (5EA) stock hit Wall Street targets2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Will Elanco Animal Health Incorporated (5EA) stock outperform benchmarksJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - newser.com
Is Elanco Animal Health Incorporated stock a buy during volatile markets2025 Valuation Update & Fast Moving Stock Trade Plans - newser.com
Best data tools to analyze Elanco Animal Health Incorporated stockJuly 2025 Pullbacks & Proven Capital Preservation Tips - newser.com
Why institutional investors increase stakes in Elanco Animal Health Incorporated stock2025 Momentum Check & Real-Time Market Trend Scan - newser.com
Is Elanco Animal Health Incorporated meeting your algorithmic filter criteriaCEO Change & Weekly Momentum Picks - newser.com
Will Elanco Animal Health Incorporated (5EA) stock boost dividends furtherJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Elanco Animal Health Incorporated stock prediction for this week2025 Dividend Review & Weekly Setup with ROI Potential - newser.com
What to expect from Elanco Animal Health Incorporated in the next 30 days2025 Price Targets & Weekly High Return Opportunities - newser.com
Pet Healthcare Spending Is Soaring. These Stocks Are Positioned to Clean Up - AOL.com
Is Elanco Animal Health Incorporated (5EA) stock positioned for digital growth era2025 Price Action Summary & Low Drawdown Momentum Ideas - Fundação Cultural do Pará
Pet Healthcare Spending Is Soaring. These 5 Stocks Are Positioned to Clean Up - 24/7 Wall St.
Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human Health - Investing News Network
Elanco Animal Health Incorporated’s volatility index tracking explainedShort Setup & Weekly High Conviction Trade Ideas - newser.com
Elanco (NYSE: ELAN) teams with Alloy to launch OneHealth Studio for One Health innovation - Stock Titan
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.50%
1.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):